Downregulation of AATK mediates microRNA-558-induced resistance of A549 cells to radiotherapy

Zhu,Rui‑Xia; Song,Chun‑Hui; Yang,Jin‑Shan; Yi,Qing‑Ting; Li,Bao‑Jian; Liu,Si‑Hai

doi:10.3892/mmr.2016.5579

Downregulation of AATK mediates microRNA-558-induced resistance of A549 cells to radiotherapy

Authors:
- Rui‑Xia Zhu
- Chun‑Hui Song
- Jin‑Shan Yang
- Qing‑Ting Yi
- Bao‑Jian Li
- Si‑Hai Liu
View Affiliations

Affiliations: Department of Oncology, Central Hospital of Zaozhuang Mineral Group, Zaozhuang, Shandong 277800, P.R. China
Published online on: August 1, 2016 https://doi.org/10.3892/mmr.2016.5579
Pages: 2846-2852

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The deregulation of microRNAs (miRNAs) is often implicated in the control of sensitivity to radiotherapy. The objective of the present study was to identify the association between miR‑558 and apoptosis‑associated tyrosine kinase (AATK), and their importance in regulating the development of resistance to radiotherapy. The current study demonstrated that AATK, a radiosensitization-associated gene, is a target of miR‑558 in lung cancer cells, using in silico analysis and a luciferase reporter system. Furthermore, it was determined that transfection of 30 or 50 nM miR‑558 mimics and AATK specific siRNA markedly suppressed the mRNA and protein expression of AATK. To determine whether miR‑558 was required for lung cancer cell radioresistance, A549 cells were treated with different doses of ionizing radiation, from 0 to 10 Gy, following transfection with miR‑558 mimics or AATK specific siRNA. It was determined that the administration of miR‑558 mimics or AATK specific siRNA alone did not significantly alter the survival rate of the cells. By contrast, in the cells exposed to 4, 6 or 8 Gy, the administration of miR‑558 mimics or AATK specific siRNA significantly promoted cell survival rate and overexpression of AATK reversed this effect. In conclusion, these data demonstrate that the miR‑558/AATK cascade is important for the radiosensitization of lung cancer cells and may be a potential radiotherapy target.

View Figures

View References

1	Sun X, Liu W, Wu S, Han H, Lin Y and Dai X: The morbidity and mortality trend and prediction of lung cancer in residents of Nangang District of Harbin in China during the past 10 years. Zhongguo Fei Ai Za Zhi. 8:514–517. 2005.PubMed/NCBI
2	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
3	Fidias P and Novello S: Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer. J Clin Oncol. 28:5116–5123. 2010. View Article : Google Scholar : PubMed/NCBI
4	Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, Minna JD, Michnoff C, Hao W, Roth MG, et al: Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature. 446:815–819. 2007. View Article : Google Scholar : PubMed/NCBI
5	Blackstock AW and Govindan R: Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. J Clin Oncol. 25:4146–4152. 2007. View Article : Google Scholar : PubMed/NCBI
6	Salama JK and Vokes EE: New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol. 31:1029–1038. 2013. View Article : Google Scholar : PubMed/NCBI
7	Le Pechoux C: Role of postoperative radiotherapy in resected non-small cell lung cancer: A reassessment based on new data. Oncologist. 16:672–681. 2011. View Article : Google Scholar : PubMed/NCBI
8	Barcellos-Hoff MH, Park C and Wright EG: Radiation and the microenvironment-tumorigenesis and therapy. Nat Rev Cancer. 5:867–875. 2005. View Article : Google Scholar : PubMed/NCBI
9	Madani I, De Neve W and Mareel M: Does ionizing radiation stimulate cancer invasion and metastasis? Bull Cancer. 95:292–300. 2008.PubMed/NCBI
10	McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M and Liao YP: A sense of danger from radiation. Radiat Res. 162:1–19. 2004. View Article : Google Scholar : PubMed/NCBI
11	Rödel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R and Rödel C: Survivin as a radioresistance factor and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res. 65:4881–4887. 2005. View Article : Google Scholar
12	Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn J and Song JY: An effective strategy for increasing the radiosensitivity of human lung cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radic Biol Med. 53:807–816. 2012. View Article : Google Scholar : PubMed/NCBI
13	Provencio M, Sánchez A, Garrido P and Valcárcel F: New molecular targeted therapies integrated with radiation therapy in lung cancer. Clin Lung Cancer. 11:91–97. 2010. View Article : Google Scholar : PubMed/NCBI
14	Danesi R, Pasqualetti G, Giovannetti E, Crea F, Altavilla G, Del Tacca M and Rosell R: Pharmacogenomics in non-small-cell lung cancer chemotherapy. Adv Drug Deliv Rev. 61:408–417. 2009. View Article : Google Scholar : PubMed/NCBI
15	Hutvagner G and Zamore PD: A microRNA in a multiple-turnover RNAi enzyme complex. Science. 297:2056–2060. 2002. View Article : Google Scholar : PubMed/NCBI
16	Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ and Plasterk RH: Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15:2654–2659. 2001. View Article : Google Scholar : PubMed/NCBI
17	Westermann F and Schwab M: Genetic parameters of neuroblastomas. Cancer Lett. 184:127–147. 2002. View Article : Google Scholar : PubMed/NCBI
18	Dewey WC, Ling CC and Meyn RE: Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys. 33:781–796. 1995. View Article : Google Scholar : PubMed/NCBI
19	Ma S and Rubin BP: Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma. Lab Invest. 94:430–438. 2014. View Article : Google Scholar : PubMed/NCBI
20	Purnell PR, Mack PC, Tepper CG, Evans CP, Green TP, Gumerlock PH, Lara PN, Gandara DR, Kung HJ and Gautschi O: The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells. J Thorac Oncol. 4:448–454. 2009. View Article : Google Scholar : PubMed/NCBI
21	Kos A, Olde Loohuis NF, Wieczorek ML, Glennon JC, Martens GJ, Kolk SM and Aschrafi A: A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase. PLoS One. 7:e310222012. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Adie EA, Adams RR, Evans KL, Porteous DJ and Pickard BS: SUSPECTS: Enabling fast and effective prioritization of positional candidates. Bioinformatics. 22:773–774. 2006. View Article : Google Scholar : PubMed/NCBI
24	Vlodavsky I, Ilan N, Naggi A and Casu B: Heparanase: Structure, biological functions and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des. 13:2057–2073. 2007. View Article : Google Scholar
25	Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I and Ilan N: Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation. Cancer Res. 66:1455–1463. 2006. View Article : Google Scholar : PubMed/NCBI
26	Parsons SJ and Parsons JT: Src family kinases, key regulators of signal transduction. Oncogene. 23:7906–7909. 2004. View Article : Google Scholar : PubMed/NCBI
27	Mazurenko NN, Kogan EA, Zborovskaya IB and Kisseljov FL: Expression of pp60c-src in human small cell and non-small cell lung carcinomas. Eur J Cancer. 28:372–377. 1992. View Article : Google Scholar : PubMed/NCBI
28	Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R and Yeatman TJ: Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet. 21:187–190. 1999. View Article : Google Scholar : PubMed/NCBI
29	Kiefer PE, Bepler G, Kubasch M and Havemann K: Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Cancer Res. 47:6236–6242. 1987.PubMed/NCBI
30	Navarro A, Beà S, Fernández V, Prieto M, Salaverria I, Jares P, Hartmann E, Mozos A, López-Guillermo A, Villamor N, et al: MicroRNA expression, chromosomal alterations and immunoglobulin variable heavy chain hypermutations in mantle cell lymphomas. Cancer Res. 69:7071–7078. 2009. View Article : Google Scholar : PubMed/NCBI
31	Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P and Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep. 23:997–1003. 2010.PubMed/NCBI
32	Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 10:3672010. View Article : Google Scholar : PubMed/NCBI
33	Arora H, Qureshi R, Jin S, Park AK and Park WY: miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1. Exp Mol Med. 43:298–304. 2011. View Article : Google Scholar : PubMed/NCBI
34	Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, et al: The colorectal microRNAome. Proc Natl Acad Sci USA. 103:3687–3692. 2006. View Article : Google Scholar : PubMed/NCBI
35	Maes OC, An J, Sarojini H, Wu H and Wang E: Changes in MicroRNA expression patterns in human fibroblasts after low-LET radiation. J Cell Biochem. 105:824–834. 2008. View Article : Google Scholar : PubMed/NCBI
36	Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H and Hu C: Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol. 139:223–229. 2013. View Article : Google Scholar :
37	Shohet JM, Ghosh R, Coarfa C, Ludwig A, Benham AL, Chen Z, Patterson DM, Barbieri E, Mestdagh P, Sikorski DN, et al: A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res. 71:3841–3851. 2011. View Article : Google Scholar : PubMed/NCBI